StockData

Drugs Made In America Acquisition II Corp. (DMII) stock

DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.24+0.00 (+0.05%)

Close on Nov 17, 2026Market cap $140.36MP/E –Yield –

Drugs Made In America Acquisition II enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Drugs Made In America Acquisition II's enterprise value was $140.56M on Nov 11, 2026.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$140.56M-8.7%
2025Dec 31, 2025$153.88M–

More Drugs Made In America Acquisition II figures

See a number that looks wrong?